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Osteomyelitis is a common manifestation of invasive
Staphylococcus aureus infection. Pathogen-induced
bone destruction limits antimicrobial penetration to
the infectious focus and compromises treatment
of osteomyelitis. To investigate mechanisms of
S. aureus-induced bone destruction, we developed
a murine model of osteomyelitis. Microcomputed
tomography of infected femurs revealed that
S. aureus triggers profound alterations in bone
turnover. The bacterial regulatory locus sae was
found to be critical for osteomyelitis pathogenesis,
as Sae-regulated factors promote pathologic bone
remodeling and intraosseous bacterial survival.
Exoproteome analyses revealed the Sae-regulated
protease aureolysin as a major determinant of the
S. aureus secretome and identified the phenol-
soluble modulins as aureolysin-degraded, osteolytic
peptides that trigger osteoblast cell death and bone
destruction. These studies establish a murine model
for pathogen-induced bone remodeling, define Sae
as critical for osteomyelitis pathogenesis, and iden-
tify protease-dependent exoproteome remodeling
as a major determinant of the staphylococcal viru-
lence repertoire.
INTRODUCTION
Osteomyelitis is one of the most common invasive manifesta-
tions of Staphylococcus aureus infection, and S. aureus is the
most frequent etiologic agent of musculoskeletal infection (Lew
and Waldvogel, 2004). In children, staphylococcal osteomyelitis
accounts for approximately 2.5 out of every 1,000 hospital
admissions, with annual incidence estimates ranging from 1 inCell H5,000 to 1 in 10,000 (Gerber et al., 2009; Weichert et al., 2008).
Among adults, osteomyelitis frequently complicates such co-
morbidities as open fractures, contiguous soft-tissue infections,
and diabetes (Lew and Waldvogel, 1997). However, in the era of
community-acquired methicillin-resistant S. aureus (CA-MRSA),
osteomyelitis now most frequently occurs in patients who have
no appreciable risk factors for invasive staphylococcal infection.
Treatment of osteomyelitis is complex and typically involves
one or more surgical debridements followed by prolonged anti-
microbial therapy. Even with an appropriate antimicrobial
regimen, patients suffering from staphylococcal osteomyelitis
frequently experience serious, life-threatening complications
such as septicemia, venous thrombosis, and pathologic frac-
tures (Belthur et al., 2012; Gonzalez et al., 2006). Such complica-
tions are related to the ability of S. aureus to incite significant
bone destruction, trigger surrounding soft-tissue inflammation,
and ultimately disseminate via the bloodstream. Bone destruc-
tion during osteomyelitis also confounds therapy by limiting anti-
microbial penetration to the infectious focus. For this reason,
prolonged antimicrobial treatment is required for osteomyelitis.
An enhanced understanding of the mechanisms that promote
bone destruction during osteomyelitis could facilitate develop-
ment of therapies that limit bone destruction, thus improving
the efficacy of current antimicrobials while reducing adverse out-
comes. However, little is known regarding the specific bacterial
factors that promote bone destruction during osteomyelitis.
Previous in vitro studies have investigated the interaction
between S. aureus and the cells responsible for bone remodel-
ing, osteoblasts and osteoclasts. S. aureus is capable of
invading and persisting within osteoblasts (Ellington et al.,
1999; Hudson et al., 1995). The interaction of S. aureus and
osteoblasts leads to physiologic alterations that favor bone
resorption by two primary mechanisms. First, S. aureus-infected
osteoblasts incite osteoclastogenesis through increased
expression of proinflammatory cytokines and the critical osteo-
clast-activating molecule receptor activator of NF-kB ligand
(RANK-L) (Claro et al., 2013; Marriott et al., 2004; Somayaji
et al., 2008). Second, S. aureus invasion of osteoblasts resultsost & Microbe 13, 759–772, June 12, 2013 ª2013 Elsevier Inc. 759
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ever, the specific staphylococcal factors that trigger osteoblast
cell death or induce osteoclastogenesis are unknown. Further-
more, it has yet to be determined whether these in vitro phenom-
ena are responsible for pathogen-mediated bone destruction
in vivo.
In this manuscript, a murine model of osteomyelitis is estab-
lished to investigate staphylococcal factors contributing to the
pathogenesis of osteomyelitis. Through the use of high-resolu-
tion microcomputed tomography (microCT), global proteomic
analyses, and cell culture assays, specific staphylococcal viru-
lence factors that contribute to pathologic bone remodeling
and intraosseous bacterial survival are identified. Additionally,
a significant role is identified for the secreted protease aureolysin
in shaping the staphylococcal virulence repertoire during inva-
sive infection. The tools developed in this work are readily adapt-
able to a variety of bacterial species, allowing for detailed ana-
lyses of the interaction between bacterial pathogens and bone.
RESULTS
Establishment of a Murine Model of Osteomyelitis for
the Study of Pathologic Bone Remodeling and
Intraosseous Bacterial Survival
For interrogation of the mechanisms of pathologic bone remod-
eling and intraosseous bacterial survival during osteomyelitis, a
murinemodel was created. Derivatives of theUSA300 type strain
LAC were used as the wild-type (WT) for all infections, as
USA300 type clinical isolates are common causes of musculo-
skeletal infections in both adults and children (Carrillo-Marquez
et al., 2009; Peyrani et al., 2012). For induction of osteomyelitis,
13 106 colony-forming units (cfu) ofS. aureus are inoculated into
the intramedullary canal of murine femurs after the creation of a
1 mm unicortical bone defect. Infected femurs exhibit peak bac-
terial burdens by day 4 postinfection (data not shown) and
display profound changes in bone remodeling surrounding the
inoculation site by day 14 postinfection. In addition to progres-
sive cortical bone destruction at the inoculation site, infected
femurs display marked new bone formation peripheral to the in-
fectious focus (Figure 1A). In contrast, mice mock infected with
sterile PBS experience healing of the surgically induced cortical
bone defect by day 14 postinfection (Figure 1B). For quantifica-
tion of both cortical bone destruction and peripheral new bone
formation, imaging analysis algorithmswere created and applied
to images of both infected and mock-infected femurs. Infected
femurs sustain significantly more cortical bone destruction and
peripheral new bone formation than do mock-infected femurs
(Figure 1C and 1D). Quantitative imaging analyses underscored
the magnitude of changes in bone remodeling during osteomye-
litis, as infected femurs lost approximately 10%–20% of total
cortical volume near the infectious focus, while peripheral new
bone formation accounted for bone growth of approximately
30%–50% of the entire original cortical volume (data not shown).
Histopathologic examination confirmed microCT findings, while
also demonstrating substantial abscess formation throughout
the bone marrow of infected femurs (Figure 1E). In contrast,
the bone marrow architecture of mock-infected femurs remains
intact (Figure 1F). Collectively, these results establish a murine
model of staphylococcal osteomyelitis amenable to imaging760 Cell Host & Microbe 13, 759–772, June 12, 2013 ª2013 Elsevieranalysis of pathologic bone remodeling and demonstrate that
S. aureus infection incites profound changes in bone turnover.
S. aureus-Secreted Virulence Factors Contribute to the
Pathogenesis of Osteomyelitis
Based on the distinct zones of cortical bone destruction and
peripheral new bone formation surrounding the inoculation site
in infected murine femurs, we hypothesized that secreted staph-
ylococcal factors trigger concentration-dependent changes in
bone remodeling and enhance bacterial survival in the bone.
So that this hypothesis could be tested, mice were infected
with a S. aureus strain rendered exoprotein-deficient by virtue
of mutations in the global regulatory loci agr and sae (Dagr/
sae). SDS-PAGE analysis of concentrated culture supernatants
confirmed that in comparison to theWT, Dagr/sae has a severely
limited exoprotein profile, with inactivation of either agr (Dagr) or
sae (Dsae) alone havingmoremodest effects (Figure S1 available
online). For investigation of the contribution of the agr and sae
loci to the pathogenesis of S. aureus osteomyelitis, groups of
mice were infected with either WT or Dagr/sae. At 14 days post-
infection, infected femurs were harvested and either subjected
to microCT imaging or processed to quantify bacterial burdens.
Femurs infected with Dagr/sae have significantly less cortical
bone destruction and peripheral new bone formation when
compared to the WT (Figures 2A–2D). Additionally, femurs
infected with Dagr/sae have significantly lower bacterial burdens
than WT-infected femurs (Figure 2E). Together, these results
reveal that the agr and sae regulatory loci are critical to the path-
ogenesis of S. aureus osteomyelitis and suggest that Agr- or
Sae-regulated virulence factors contribute to pathologic bone
remodeling and intraosseous bacterial survival.
The sae Regulatory Locus Contributes to Pathologic
Bone Remodeling and Intraosseous Bacterial Survival
during S. aureus Osteomyelitis
For further delineation of specific S. aureus virulence factors that
contribute to pathologic bone remodeling and intraosseous
bacterial survival during osteomyelitis, mice were infected with
strains inactivated for either agr (Dagr) or sae (Dsae) and
compared toWT-infectedmice. At 14 days postinfection, femurs
were harvested and subjected to microCT imaging or processed
to quantify bacterial burdens. Murine femurs infected with Dsae
sustain significantly less cortical bone destruction and new bone
formation than WT-infected femurs (Figures 3A–3F). Moreover,
Dsae-infected femurs have a significant decrease in bacterial
burdens when compared to WT-infected femurs, showing a
similar reduction to that observed in Dagr/sae-infected femurs
(Figure 3G). Conversely, murine femurs infected with Dagr
exhibit no significant change in bacterial burdens relative to
WT-infected femurs, but sustain significantly less cortical bone
destruction (Figure S2). Collectively, these studies define the
sae and agr regulatory loci as contributors to pathologic bone re-
modeling during S. aureus osteomyelitis, with sae also signifi-
cantly impacting intraosseous bacterial survival.
Sae-Regulated Secreted Virulence Factors Are
Cytotoxic to Osteoblasts
In vivo studies revealed a critical role for the sae regulatory locus
in the pathogenesis of S. aureus osteomyelitis. In order toInc.
Figure 1. S. aureus Triggers Pathologic Bone Remodeling during Osteomyelitis
Groups of mice were subjected to experimental osteomyelitis via intramedullary inoculation of either S. aureus strain LAC (WT) or an equivalent volume of sterile
PBS (mock). Femurs were harvested at 14 days postinoculation and subjected to microCT analysis.
(A) Anteroposterior (left) and lateral (right) views of a S. aureus-infected femur at 14 days postinoculation. Asterisk denotes inoculation site and surrounding
cortical bone destruction. Arrowheads denote peripheral new bone formation.
(B) Anteroposterior (left) and lateral (right) views of a mock-infected femur at 14 days postinoculation. Asterisk denotes inoculation site.
(C and D)MicroCT imaging analysis of cortical bone destruction (C) and new bone formation (D) in infected femurs at day 14 postinoculation. n = 4mice per group.
Error bars indicate the SEM. *p < 0.05 and **p < 0.01 relative to WT infection as calculated by a Student’s t test.
(E and F) Modified hematoxylin and eosin (H&E)-phloxine-orange-G-stained sections of representative WT-infected (E) or mock-infected (F) femurs at low (left) or
high (right) magnification. High-magnification images are centered over the inoculation site and represent different tissue depths from the same femurs in low-
magnification images. Arrows denote inoculation site, arrowheads denote peripheral new bone formation, and asterisks denote abscesses.
Cell Host & Microbe
S. aureus Exoproteins Modulate Bone Remodelinginvestigate the mechanism by which Sae-regulated virulence
factors perturb bone remodeling, a cytotoxicity assaywas devel-
oped with murine (MC3T3) and human (Saos-2) osteoblastic
cells. Incubation of MC3T3 or Saos-2 cell monolayers with
concentrated culture supernatant from WT S. aureus results in
potent cytotoxicity (Figures 4A and 4B). Cytotoxicity is observed
as early as 2 hr after the addition of culture supernatant (data not
shown). Incubation of MC3T3 cell monolayers with varying
amounts of unconcentrated culture supernatant revealed that
cytotoxicity is dose dependent (Figure 4C). Inactivation of the
sae locus leads to a complete loss of cytotoxicity in both murine
and human osteoblastic cells after intoxication with concen-
trated supernatant (Figures 4A and 4B). However, when osteo-Cell Hblast monolayers are incubated with unconcentrated culture
supernatant from Dsae, a significant increase in cytotoxicity
relative to concentrated supernatant preparations is observed
(Figure 4A). Importantly, the enhanced cytotoxicity of unconcen-
tratedDsae supernatant was not explained simply by differences
in protein abundance in the concentrated versus unconcen-
trated samples, as roughly equivalent final protein concentra-
tions were added to cell monolayers (data not shown). Rather,
as supernatant concentration required an additional 3 hr of
sample processing, an alternative explanation is that loss of
cytotoxicity in Dsae concentrated culture supernatant is due
to increased degradation of osteolytic factors over time.
Together, these results reveal that secreted S. aureus factorsost & Microbe 13, 759–772, June 12, 2013 ª2013 Elsevier Inc. 761
Figure 2. S. aureus-Secreted Virulence Factors Contribute to Pathologic Bone Remodeling and Intraosseous Bacterial Survival during
Osteomyelitis
Groups ofmicewere subjected to experimental osteomyelitis via inoculation ofWT orDagr/sae. Femurs were harvested at 14 days postinoculation and subjected
to microCT imaging analysis or processed for enumeration of bacterial burdens.
(A and B) Anteroposterior views of WT- (A) or Dagr/sae- (B) infected femurs at 14 days postinoculation.
(C and D)MicroCT imaging analysis of cortical bone destruction (C) and new bone formation (D) in infected femurs at day 14 postinoculation. n = 4mice per group.
Error bars indicate the SEM. *p < 0.05 relative to the WT as calculated by a Student’s t test.
(E) Colony-forming unit (cfu) recovery permilligramof bone tissue at day 14 postinoculation. n = 9 (Dagr/sae) or n = 10 (WT) per group. ***p < 0.001 as calculated by
a Student’s t test. Horizontal bars represent the mean of log cfu/mg of bone.
See also Figure S1.
Cell Host & Microbe
S. aureus Exoproteins Modulate Bone Remodelingare dose-dependently cytotoxic to both human andmurine oste-
oblastic cells and suggest that these osteolytic factors experi-
ence enhanced degradation in the absence of Sae.
Analysis of the Sae Exoproteome Identifies Aureolysin
as a Significant Determinant of the S. aureus-Secreted
Virulence Repertoire
Osteoblast cytotoxicity assays suggested that S. aureus
secretes osteolytic factors that experience enhanced degrada-
tion in the absence of Sae. For identification of Sae-regulated
exoproteins that elicit osteoblast cell death and contribute to
the pathogenesis of S. aureus osteomyelitis, the Sae exopro-
teome was determined. Multidimensional protein identification
technology (MudPIT) analyses were performed on concentrated
culture supernatants from WT and Dsae. Spectral counts were
determined and used as a measure of protein abundance. Inac-
tivation of sae leads to a significant decrease in the abundance of762 Cell Host & Microbe 13, 759–772, June 12, 2013 ª2013 Elsevier49 proteins, including secreted virulence factors such as cyto-
toxins (Hla, LukA, LukB, HlgA, HlgC, and PVL), immunomodula-
tory molecules (CHIPS, Sbi, and Fprl1 inhibitory protein), and
exoenzymes (SplA-F and Nuc) (Table 1). A file containing all pro-
teins that change in abundance upon inactivation of sae is also
included in the Supplemental Information (Table S1). Thirty-one
proteins significantly increase in abundance upon inactivation
of sae, and of these, the secreted protease aureolysin is most
altered, increasing 8-fold (Table 1 and Table S1). Based on the
observation that inactivation of sae leads to decreased abun-
dance of osteolytic factors (Figure 4A) and globally altered exo-
protein patterns (Figure S1), we hypothesized that aureolysin
activity might significantly modify the Sae exoproteome. There-
fore, the exoproteome of a strain inactivated for both sae and
aur (Dsae/aur) was determined. Concomitant inactivation of
sae and aur leads to profound changes in the exoproteome,
with 230 proteins significantly increasing in abundance and 51Inc.
Figure 3. The sae Regulatory Locus Contributes to Pathologic Bone Remodeling and Intraosseous Bacterial Survival during S. aureus
Osteomyelitis
Groups of mice were subjected to experimental osteomyelitis via inoculation of WT or Dsae. Femurs were harvested at 14 days postinoculation and subjected to
microCT imaging analysis or processed for enumeration of bacterial burdens.
(A and B) Anteroposterior views of WT- (A) or Dsae- (B) infected femurs at 14 days postinoculation.
(C and D)MicroCT imaging analysis of cortical bone destruction (C) and new bone formation (D) in infected femurs at day 14 postinoculation. n = 5mice per group.
Error bars indicate the SEM. ***p < 0.001 relative to the WT as calculated by a Student’s t test.
(E and F) Modified H&E-phloxine-orange-G-stained sections of representative WT-infected (E) or Dsae-infected (F) femurs at low magnification. Arrows denote
inoculation site, and arrowheads denote peripheral new bone formation.
(G) Colony-forming unit (cfu) recovery per milligram of bone tissue at day 14 postinoculation. n = 10 per group. ***p < 0.001 as calculated by a Student’s t test.
Horizontal bars represent the mean of log cfu/mg of bone.
See also Figure S2.
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(Table 2 and Table S2). Of the 269 proteins that decrease in
abundance upon inactivation of sae, 225 (83%) increase in abun-
dance upon concomitant inactivation of aur, with 190 (84%) of
these proteins either returning to or exceeding WT protein levels
(Table S2). Thus, the Sae exoproteome is significantly impacted
by the activity of aureolysin, with the majority of Sae-regulated
exoproteins experiencing aureolysin-dependent changes in
abundance. These findings support a model whereby the Sae-Cell Hregulated protease aureolysin remodels the staphylococcal exo-
proteome to modulate virulence.
Inactivation of Aureolysin in the Dsae Background
Restores Osteoblast Cytotoxicity and Increases Cortical
Bone Destruction
Exoproteome analyses revealed that themajority of proteins that
decrease in abundance upon inactivation of sae do so in an
aureolysin-dependent manner. We therefore hypothesized thatost & Microbe 13, 759–772, June 12, 2013 ª2013 Elsevier Inc. 763
Figure 4. Sae-Regulated Secreted Viru-
lence Factors Are Dose-Dependently Cyto-
toxic to Osteoblasts
(A and B) MC3T3 murine osteoblastic cells (A) or
Saos-2 human osteoblastic cells (B) were seeded
into 96-well plates at 5,000 cells per well or
10,000 cells per well, respectively. After 24 hr,
growth media were replaced, and 40 ml concen-
trated culture supernatant, 160 ml unconcentrated
supernatant, or an equivalent volume of sterile
RPMI supplemented with 1% casamino acids
(control) was added to cell monolayers. Osteoblast
viability was assessed 23 hr later with the Promega
CellTiter 96 AQueous One kit, and results are
expressed as percent of control. n = 10 per group
and results are representative of at least three in-
dependent experiments. Error bars indicate the
SEM. ***p < 0.001 as calculated by a Student’s
t test.
(C) MC3T3 cells were seeded into 96-well plates at
a density of 2,500 cells per well. Twenty-four hours
after seeding, growth media were replaced and
varying amounts of unconcentrated culture
supernatant were added to cell monolayers. Cell
viability was assessed as above. n = 10 per group.
Error bars indicate the SEM.
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preparations from Dsae was due to aureolysin-mediated degra-
dation of osteolytic exoproteins. So that this hypothesis could be
tested, concentrated culture supernatants were prepared from
Dsae and Dsae/aur, and each preparation was tested for the
ability to induce cell death in murine or human osteoblasts. Inac-
tivation of aur in the Dsae background restores cytotoxicity to
levels equivalent to theWT in both murine (Figure 5A) and human
(data not shown) osteoblasts. For investigation of whether the
increased osteoblast cytotoxicity observed with Dsae/aur corre-
lates to increased bone destruction during osteomyelitis, groups
of mice were infected with WT, Dsae, or Dsae/aur. At 14 days
postinfection, femurs were harvested and imaged by microCT
or processed to quantify bacterial burdens. Concomitant inacti-
vation of aur does not lead to a significant increase in bacterial
recovery from infected femurs relative to inactivation of sae alone
(Figure 5B). Despite this, inactivation of aur in the Dsae back-
ground leads to a significant increase in cortical bone destruc-
tion (Figure 5C). Taken together, these results demonstrate
that inactivation of Sae causes increased abundance of aureoly-
sin, which decreases levels of osteolytic factors and thereby
significantly reduces cortical bone destruction. Thus, modula-
tion of the S. aureus virulence repertoire by a secreted protease
impacts pathogenesis.
Alpha-Type Phenol-Soluble Modulins Are Cytotoxic to
Murine and Human Osteoblastic Cells and Contribute to
Pathogen-Induced Bone Destruction during
Osteomyelitis
Exoproteome analyses revealed proteins with altered abun-
dance upon inactivation of sae or concomitant inactivation of
sae and aur. As cytotoxicity was observed with concentrated
supernatants from WT and Dsae/aur, but not Dsae, the exopro-
teomes were analyzed to identify proteins that were detected
only in cytotoxic supernatant preparations. The alpha-type764 Cell Host & Microbe 13, 759–772, June 12, 2013 ª2013 Elsevierphenol-soluble modulins (PSMs) PSMa1 and PSMa2 were pre-
sent only in the exoproteomes of WT and Dsae/aur, but not in
the exoproteome of Dsae (Table S2). Similarly, PSMa4 is present
at lower levels in the exoproteome of Dsae as compared to WT
and Dsae/aur. The alpha-type PSMs are cytolytic peptides that
lyse neutrophils, provoke chemotaxis, and contribute to CA-
MRSA virulence (Wang et al., 2007). Additionally, alpha-type
PSMs undergo processing by secreted proteases, including
aureolysin (Gonzalez et al., 2012; Zielinska et al., 2011). How-
ever, the role of PSMs in the pathogenesis of osteomyelitis has
not been previously investigated. For testing of the hypothesis
that alpha-type PSMs are responsible for osteoblast cytotox-
icity, genes encoding the alpha-type PSMs were inactivated in
the WT background and concentrated culture supernatant was
prepared from this strain. Inactivation of the alpha-type PSMs
(Dpsma1-4) leads to a complete loss of cytotoxicity toward
both murine and human osteoblastic cells (Figures 5D and 5E),
indicating that these peptides are responsible for the cytotoxicity
observed with concentrated culture supernatant from WT
S. aureus. For direct testing of the ability of PSMs to trigger oste-
oblast cell death, PSMa1, PSMa2, PSMa3, and PSMa4 were
synthesized and added directly to MC3T3 or Saos-2 mono-
layers. PSMa1, PSMa2, and PSMa3 are each dose-dependently
cytotoxic to murine and human osteoblasts, with PSMa2 being
the most potent (Figures S3A and 3B). In contrast, PSMa4
does not elicit cytotoxicity at concentrations up to 100 mg/ml.
For investigation of the impact of aureolysin-mediated process-
ing of PSMs on osteoblast cytotoxicity, PSMa2 and PSMa3were
incubated with purified aureolysin prior to intoxication of MC3T3
monolayers. We were unable to test the effect of aureolysin pro-
cessing on PSMa1-mediated cytotoxicity due to loss of activity
of this peptide after incubation at 37C (data not shown). Pre-
treatment of PSMa2 and PSMa3 with aureolysin, but not heat-
inactivated aureolysin or buffer control, significantly limits
osteoblast cytotoxicity (Figure S3C). So that the contribution ofInc.








Significantly Decreased: Toxins, Proteases, and Exoenzymes
Q2FHS2jQ2FHS2_STAA3 242.3333 0.6667 363.5000 Alpha-hemolysin; SAUSA300_1058 0.0014
Q2FFA2jLUKL2_STAA3 157.6667 1.0000 157.6667 LukB; SAUSA300_1975 0.0270
Q2FFA3jLUKL1_STAA3 152.6667 0.0000 152.6667 LukA; SAUSA300_1974 0.0117
Q2FE78jQ2FE78_STAA3 53.6667 0.6667 80.5000 Gamma-hemolysin component A; HlgA 0.0100
Q2FFT1jSPLC_STAA3 24.3333 0.6667 36.5000 Serine protease SplC 0.0242
Q2FJP4jQ2FJP4_STAA3 58.6667 1.6667 35.2000 Putative staphylococcal enterotoxin; SAUSA300_0370 0.0080
Q2FJV7jQ2FJV7_STAA3 67.0000 2.0000 33.5000 50-nucleotidase, lipoprotein e(P4) family; SAUSA300_0307 0.0024
Q2FFS9jSPLA_STAA3 57.6667 2.6667 21.6250 Serine protease SplA 0.0272
Q2FFT2jSPLD_STAA3 71.0000 5.3333 13.3125 Serine protease SplD 0.0203
Q2FE77jQ2FE77_STAA3 19.0000 1.6667 11.4000 Gamma-hemolysin component C; HlgC 0.0150
Q2FFT0jSPLB_STAA3 261.6667 24.0000 10.9028 Serine protease SplB 0.0150
Q2FGV0jQ2FGV0_STAA3 600.0000 58.0000 10.3448 Panton-Valentine leukocidin, LukF-PV 0.0150
Q2FI16jQ2FI16_STAA3 6.6667 0.6667 10.0000 Chitinase-related protein; SAUSA300_0964 0.0427
Q2FFT4jSPLF_STAA3 75.3333 8.0000 9.4167 Serine protease SplF 0.0217
Q2FJL6jQ2FJL6_STAA3 6.0000 0.6667 9.0000 Exotoxin; SAUSA300_0398 0.0399
Q2FFR8jQ2FFR8_STAA3 26.6667 3.3333 8.0000 Leukotoxin LukE 0.0178
Q2FFT3jSPLE_STAA3 93.6667 12.6667 7.3947 Serine protease SplE 0.0279
Q2FIK2jQ2FIK2_STAA3 216.6667 30.0000 7.2222 Thermonuclease; Nuc 0.0148
Q2FGU9jQ2FGU9_STAA3 191.0000 61.0000 3.1311 Panton-Valentine leukocidin, LukS-PV 0.0446
Significantly Decreased: Immunomodulatory
Q2FE79jSBI_STAA3 85.6667 0.3333 257.0000 Immunoglobulin-binding protein Sbi 0.0153
Q2FFF7jCHIPS_STAA3 856.0000 7.6667 111.6522 Chemotaxis inhibitory protein; Chp 0.0034
Q2FHS7jFLIPR_STAA3 10.0000 0.0000 10.0000 FPRL1 inhibitory protein; Flr 0.0150
Significantly Decreased: Regulatory
Q2FIT2jQ2FIT2_STAA3 235.3333 0.0000 235.3333 SaeP; SAUSA300_0693 0.0016
Significantly Decreased: Surface/Cell-Wall Associated
Q2FE03jFNBA_STAA3 19.3333 0.3333 58.0000 Fibronectin-binding protein A; FnbA 0.0272
Q2FJK6jQ2FJK6_STAA3 30.3333 0.6667 45.5000 Putative surface protein; SAUSA300_0408 0.0063
Q2FHS5jQ2FHS5_STAA3 31.3333 0.0000 31.3333 Fibrinogen-binding protein; Efb; SAUSA300_1055 0.0014
Q2FKM6jQ2FKM6_STAA3 49.6667 2.6667 18.6250 Penicillin-binding protein 20; MecA 0.0150
Q2FHS4jQ2FHS4_STAA3 6.0000 0.0000 6.0000 Fibrinogen-binding protein; SAUSA300_1056 0.0150
Q2FHU9jQ2FHU9_STAA3 5.3333 1.6667 3.2000 IsdD; SAUSA300_1031 0.0469
Q2FF92jQ2FF92_STAA3 2.0000 0.0000 2.0000 Serine-aspartate repeat family protein, SdrH 0.0024
Significantly Increased: Toxins, Proteases, and Exoenzymes
Q2FDM2jQ2FDM2_STAA3 16.3333 134.0000 0.1219 Zinc metalloproteinase aureolysin; Aur 0.0080
Q2FKG2jQ2FKG2_STAA3 114.0000 399.3333 0.2854 1-phosphatidylinositol phosphodiesterase; Plc 0.0080
Q2FI30jQ2FI30_STAA3 50.3333 117.3333 0.4290 Cysteine protease; SspB 0.0379
Q2FFI6jQ2FFI6_STAA3 439.0000 885.6667 0.4957 Staphopain A; SAUSA300_1890 0.0178
Q2FIH7jQ2FIH7_STAA3 44.3333 79.0000 0.5612 Staphylococcal enterotoxin Q; Seq 0.0384
Q2FIH8jQ2FIH8_STAA3 27.6667 39.6667 0.6975 Staphylococcal enterotoxin K; Sek 0.0069
Significantly Increased: Regulatory
Q2FFR1jTRAP_STAA3 5.6667 18.3333 0.3091 Signal transduction protein TRAP 0.0251
Q2FHI3jCODY_STAA3 15.0000 35.3333 0.4245 GTP-sensing transcriptional pleiotropic repressor CodY 0.0279
Significantly Increased: Surface/Cell-Wall Associated
Q2FHV2jISDB_STAA3 36.6667 46.0000 0.7971 Iron-regulated surface determinant protein B; IsdB 0.0255
Q2FJ78jSDRD_STAA3 4.3333 19.0000 0.2281 Serine-aspartate repeat-containing protein D; SdrD 0.0081
Q2FDM9jQ2FDM9_STAA3 2.0000 6.6667 0.2999 Clumping factor B; ClfB 0.0272
(Continued on next page)
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Q2FJ77jSDRE_STAA3 4.0000 10.3333 0.3871 Serine-aspartate repeat-containing protein E; SdrE 0.0247
Q2FE08jQ2FE08_STAA3 57.0000 88.3333 0.6453 Putative cell-wall surface anchor family protein;
SAUSA300_2436
0.0489
See also Table S1 for a complete list of proteins that change in abundance upon inactivation of sae.
aUniprotKB nomenclature (http://www.uniprot.org).
bRatio ofmean LAC spectra divided bymean LACDsae spectra. If mean spectra equaled zero, a value of onewas used to calculate ratio. Values greater
than 1.0 indicate protein abundances decreased upon inactivation of sae. Values less than 1.0 indicate protein abundances increased upon inactiva-
tion of sae.
cFalse-discovery-rate-corrected p value as calculated by the QuasiTel program.
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osteomyelitis could be tested, groups of mice were infected with
WT or Dpsma1-4, and femurs were harvested for microCT anal-
ysis on day 14 postinfection. Inactivation of psma1-4 signifi-
cantly limits cortical bone destruction in infected femurs (30%
decrease in cortical bone destruction, p = 0.0156 relative to
the WT), demonstrating that osteoblast cytotoxicity induced by
the alpha-type PSMs correlates to increased pathogen-induced
bone destruction during osteomyelitis (Figure 5F). Collectively,
these data identify the alpha-type PSMs as Sae-regulated
osteolytic exoproteins that are targeted by aureolysin and
contribute to the morbidity of osteomyelitis. These findings
confirm that protease-mediated exoproteome remodeling im-
pacts S. aureus pathogenesis during invasive infection.
DISCUSSION
Osteomyelitis is a common and debilitating manifestation of
invasive S. aureus disease. Treatment of osteomyelitis is
compromised by pathogen-induced bone destruction, which
destroys the vascular architecture of infected bone and limits
antimicrobial penetration to the infectious focus. Therapies
aimed at limiting bone destruction during osteomyelitis could
enhance traditional antimicrobial therapy, while reducing patho-
logic sequelae. For investigation of the mechanisms by which
bacterial pathogens induce bone destruction during osteomye-
litis, a murine model of bone infection was developed, and
microCT analyses of infected femurs were used to quantify path-
ologic bone remodeling. These tools revealed that S. aureus
induces profound changes in bone remodeling, in part through
the production of osteolytic exoproteins that modulate osteo-
blast proliferation. Surprisingly, S. aureus infection also leads
to profound new bone formation, suggesting that bacterial
modulation of bone remodeling involves complex changes in
bone physiology. A crucial role for the S. aureus regulatory locus
sae is demonstrated for both pathologic bone remodeling and in-
traosseous bacterial survival. The animal model of osteomyelitis
described here demonstrates quantifiable differences in intra-
osseous bacterial survival and pathologic bone remodeling
between isogenic bacterial strains, making it a valuable tool
both for study of osteomyelitis pathogenesis and for the devel-
opment of new therapies. Furthermore, the surgical techniques
and ancillary studies associated with this animal model are easily
adaptable to other bacterial species, enabling detailed study of
host-pathogen interactions using a variety of bone pathogens.766 Cell Host & Microbe 13, 759–772, June 12, 2013 ª2013 ElsevierBy modeling the interaction between bacterial pathogens and
host cells comprising the skeletal system, these tools provide
the opportunity to discover the mechanisms underlying bone
turnover in response to infectious and inflammatory stimuli.
For identification of osteolytic exoproteins that contribute to
pathologic bone remodeling during osteomyelitis, global exo-
proteome analyses were performed. Exoproteome analysis re-
vealed a crucial role for Sae in the expression of multiple classes
of virulence factors, consistent with previous reports that Sae is
required for virulence in other animal models of staphylococcal
infection (Goerke et al., 2005; Liang et al., 2006; Nygaard et al.,
2010; Voyich et al., 2009; Xiong et al., 2006). Unexpectedly,
the secreted protease aureolysin was found to be a significant
determinant of the S. aureus exoproteome. Inactivation of Sae
leads to a significant increase in aureolysin abundance, consis-
tent with previous reports demonstrating that aureolysin is
repressed by Sae (Nygaard et al., 2010; Rogasch et al., 2006).
Thus, in addition to transcriptional regulation by Sae, our results
suggest an additional tier of regulation of the S. aureus virulence
repertoire, whereby secreted protein abundance is tailored by
the expression of a staphylococcal protease. These data corrob-
orate findings from a previous study in which inactivation of all
extracellular proteases led to changes in the S. aureus proteome
(Zielinska et al., 2012). The benefit of such posttranslational pro-
cessing of virulence factors is unknown, but it is possible that this
strategy allows S. aureus to combat the innate immune system
while limiting antigenic accessibility to the adaptive immune
response. An alternative explanation is that aureolysin-mediated
processing of the secreted virulence repertoire allows S. aureus
to modulate virulence factor production in response to host mi-
croenvironments. Staphylococcal abscesses are largely devoid
of zinc, and thus a zinc-dependent protease such as aureolysin
might allow for tailoring of the S. aureus secretome according to
nutrient availability (Corbin et al., 2008). Aureolysin activity is also
dependent on calcium, and therefore fluctuation of calcium
availability at infectious foci may also modulate the secreted
virulence repertoire (Arvidson, 1973). Finally, posttranslational
regulation of secreted proteins by aureolysin might be a mecha-
nism to govern the temporal and spatial abundance of specific
toxins, allowing for more rapid changes in protein turnover and
localization than can be achieved through transcriptional regula-
tion alone.
The alpha-type PSMs were identified as osteolytic peptides
that incite osteoblast cell death and contribute to pathogen-
induced bone destruction during osteomyelitis. These resultsInc.










Significantly Decreased: Toxins, Proteases, and Exoenzymes
Q2FHS2jQ2FHS2_STAA3 242.3333 0.6667 363.5000 0.0004 Alpha-hemolysin; SAUSA300_1058
Q2FFA3jLUKL1_STAA3 152.6667 2.6667 57.2500 0.0048 LukA; SAUSA300_1974
Q2FE78jQ2FE78_STAA3 53.6667 1.0000 53.6667 0.0040 Gamma-hemolysin component A; HlgA
Q2FFA2jLUKL2_STAA3 157.6667 4.3333 36.3846 0.0112 LukB; SAUSA300_1975
Q2FFS9jSPLA_STAA3 57.6667 2.3333 24.7143 0.0096 Serine protease SplA
Q2FFT1jSPLC_STAA3 24.3333 1.0000 24.3333 0.0101 Serine protease SplC
Q2FFT0jSPLB_STAA3 261.6667 12.0000 21.8056 0.0040 Serine protease SplB
Q2FFT3jSPLE_STAA3 93.6667 4.3333 21.6154 0.0026 Serine protease SplE
Q2FK40jQ2FK40_STAA3 19.3333 1.0000 19.3333 0.0133 Staphylocoagulase; Coa
Q2FFT4jSPLF_STAA3 75.3333 4.0000 18.8333 0.0046 Serine protease SplF
Q2FIK5jQ2FIK5_STAA3 12.0000 0.6667 18.0000 0.0208 Putative staphylocoagulase; SAUSA300_0773
Q2FFT2jSPLD_STAA3 71.0000 4.3333 16.3846 0.0049 Serine protease SplD
Q2FJL8jQ2FJL8_STAA3 4.6667 0.3333 14.0000 0.0352 Exotoxin 7; Set7
Q2FJP4jQ2FJP4_STAA3 58.6667 5.6667 10.3529 0.0040 Putative staphylococcal enterotoxin; SAUSA300_0370
Q2FGU9jQ2FGU9_STAA3 191.0000 20.3333 9.3934 0.0026 Panton-Valentine leukocidin, LukS-PV
Q2FKN2jRLMH_STAA3 3.0000 0.3333 9.0000 0.0454 Exotoxin; SAUSA300_0398
Q2FGV0jQ2FGV0_STAA3 600.0000 88.6667 6.7669 0.0049 Panton-Valentine leukocidin, LukF-PV
Q2FE77jQ2FE77_STAA3 19.0000 3.3333 5.7000 0.0125 Gamma-hemolysin component C; HlgC
Q2FIK2jQ2FIK2_STAA3 216.6667 43.0000 5.0388 0.0016 Thermonuclease; Nuc
Q2FJL3jQ2FJL3_STAA3 3.3333 0.6667 5.0000 0.0269 Exotoxin; SAUSA300_0401
Q2FJL6jQ2FJL6_STAA3 6.0000 1.3333 4.5000 0.0425 Exotoxin; SAUSA300_0398
Q2FJV7jQ2FJV7_STAA3 67.0000 20.3333 3.2951 0.0173 50-nucleotidase, lipoprotein e(P4) family; SAUSA300_0307
Q2FFR8jQ2FFR8_STAA3 26.6667 8.3333 3.2000 0.0133 Leukotoxin LukE
Q2FHS0jQ2FHS0_STAA3 6.3333 2.0000 3.1667 0.0387 Putative exotoxin 4; SAUSA300_1060
Q2FJL9jQ2FJL9_STAA3 3.0000 0.0000 3.0000 0.0127 Exotoxin; SAUSA300_0395
Q2FE76jQ2FE76_STAA3 74.6667 28.0000 2.6667 0.0381 Gamma-hemolysin component B; HlgB
Q2FFR9jQ2FFR9_STAA3 55.3333 29.6667 1.8652 0.0251 Leukotoxin LukD
Q2FJU4jQ2FJU4_STAA3 6.3333 3.6667 1.7273 0.0454 Triacylglycerol lipase; SAUSA300_0320
Q2FKN3jQ2FKN3_STAA3 39.3333 34.3333 1.1456 0.0154 50-nucleotidase family protein; SAUSA300_0025
Significantly Decreased: Immunomodulatory
Q2FFF7jCHIPS_STAA3 856.0000 6.6667 128.4000 0.0016 Chemotaxis inhibitory protein; Chp
Q2FE79jSBI_STAA3 85.6667 1.6667 51.4000 0.0070 Immunoglobulin-binding protein Sbi
Q2FHS7jFLIPR_STAA3 10.0000 1.0000 10.0000 0.0091 FPRL1 inhibitory protein; Flr
Significantly Decreased: Regulatory
Q2FKE7jQ2FKE7_STAA3 2.3333 0.6667 3.5000 0.0329 Staphylococcal accessory regulator SarS; SAUSA300_0114
Significantly Decreased: Surface/Cell-Wall Associated
Q2FE03jFNBA_STAA3 19.3333 1.0000 19.3333 0.0131 Fibronectin-binding protein A; FnbA
Q2FHS5jQ2FHS5_STAA3 31.3333 2.6667 11.7500 0.0040 Fibrinogen-binding protein; Efb
Q2FE04jQ2FE04_STAA3 4.0000 0.6667 6.0000 0.0179 Fibronectin-binding protein B; FnbB
Q2FG07jISDH_STAA3 20.0000 14.3333 1.3953 0.0454 Iron-regulated surface determinant protein H; IsdH
Q2FHV2jISDB_STAA3 36.6667 27.0000 1.3580 0.0199 Iron-regulated surface determinant protein B; IsdB
Significantly Increased: Toxins, Proteases, and Exoenzymes
Q2FG30jY1654_STAA3 0.6667 12.3333 0.0541 0.0101 Uncharacterized peptidase SAUSA300_1654;
SAUSA300_1654
Q2FHF9jQ2FHF9_STAA3 0.6667 10.6667 0.0625 0.0393 Peptidase, M16 family; SAUSA300_1172
Q2FJD0jQ2FJD0_STAA3 0.6667 8.6667 0.7693 0.0302 ATP-dependent zinc metalloprotease FtsH
Q2FIM5jCLPP_STAA3 1.6667 12.6667 0.1316 0.0189 ATP-dependent Clp protease proteolytic subunit; ClpP
(Continued on next page)
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Q2FJB5jCLPC_STAA3 4.3333 25.0000 0.1733 0.0339 ATP-dependent Clp protease ATP-binding subunit ClpC
Q2FG62jCLPX_STAA3 0.0000 3.3333 0.3000 0.0173 ATP-dependent Clp protease ATP-binding subunit ClpX
Significantly Increased: Regulatory
Q2FG02jQ2FG02_STAA3 1.3333 25.0000 0.0533 0.0389 Catabolite control protein A; CcpA
Q2FF85jQ2FF85_STAA3 0.6667 7.0000 0.0952 0.0497 Accessory gene regulator protein A; AgrA
Q2FIV3jQ2FIV3_STAA3 4.3333 33.0000 0.1313 0.0145 Transcriptional regulator, MarR family; SAUSA300_0672
Q2FJ20jSARA_STAA3 11.3333 64.6667 0.1752 0.0040 Transcriptional regulator SarA
Q2FF59jRSBW_STAA3 2.0000 8.6667 0.2308 0.0097 Serine-protein kinase RsbW
Q2FH23jARLR_STAA3 0.0000 3.3333 0.3000 0.0173 Response regulator ArlR
Significantly Increased: Surface/Cell-Wall Associated
Q2FKM6jQ2FKM6_STAA3 49.6667 239.6667 0.2072 0.0496 Penicillin-binding protein 20; MecA
Q2FGW1jEBPS_STAA3 5.6667 20.0000 0.2833 0.0417 Elastin-binding protein EbpS
See also Table S2 for a complete list of proteins that change in abundance upon concomitant inactivation of sae and aur.
aUniprotKB nomenclature (http://www.uniprot.org).
bRatio of mean LAC spectra divided by mean LACDsae/aur spectra. If mean spectra equaled zero, a value of one was used to calculate ratio. Values
greater than 1.0 indicate protein abundances decreased upon inactivation of sae and aur. Values less than 1.0 indicate protein abundances increased
upon inactivation of sae and aur.
cFalse-discovery-rate-corrected p value as calculated by the QuasiTel program.
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lence factors shapes the staphylococcal virulence repertoire.
As aureolysin is known to activate other extracellular proteases,
it is possible that PSMs are also degraded by a second, aureoly-
sin-activated secreted protease in the absence of Sae (Nicker-
son et al., 2007). However, previous studies demonstrated that
aureolysin is capable of degrading PSMs in the absence of the
S. aureus global regulator, SarA (Zielinska et al., 2011). PSM pro-
duction is also dependent on an intact agr locus, and therefore
the decreased cortical bone destruction observed in Dagr-
infected femurs may be a reflection of the absence of PSMs
(Wang et al., 2007). Interestingly, as USA300 lineage strains of
S. aureus are characterized by enhanced production of PSMs
relative to other S. aureus clinical strain lineages (Li et al.,
2009), our results may partially explain the increased morbidity
associated with USA300 strains in patients with osteomyelitis
(Carrillo-Marquez et al., 2009; Gonzalez et al., 2006).
Inactivation of aureolysin in the Dsae background did not fully
restore bone destruction to wild-type levels or significantly
impact intraosseous bacterial survival. Similarly, inactivation of
the alpha-type PSMs failed to affect pathogenesis to the same
extent as inactivation of sae. It is therefore likely that additional
Sae-regulated factors that impact the pathogenesis of osteomy-
elitis are yet to be discovered. Exoproteome analyses revealed
that Sae affects the abundance of several classes of virulence
factors, including factors that combat the innate immune sys-
tem, cytotoxins, and degradative exoenzymes. In addition to
secreted virulence factors, inactivation of Sae significantly
decreased the abundance of cell surface proteins such as fibro-
nectin- and fibrinogen-binding proteins. Therefore, the virulence
defect of Dsae may also reflect deficiencies in host-tissue bind-
ing, biofilm formation, or invasion of host cells. By defining the
Sae exoproteome and aureolysin-mediated processing of
secreted virulence factors, this work provides a foundation for
the development of immunotherapeutics that limit pathologic768 Cell Host & Microbe 13, 759–772, June 12, 2013 ª2013 Elsevierbone remodeling during osteomyelitis, thereby enhancing the
ability to treat staphylococcal musculoskeletal infection.
EXPERIMENTAL PROCEDURES
Ethics Statement
All experiments involving animals were reviewed and approved by the Institu-
tional Animal Care and Use Committee of Vanderbilt University. All experi-
ments were performed according to NIH guidelines, the Animal Welfare Act,
and US Federal law.
Bacterial Strains and Growth Conditions
All experiments were conducted with derivatives of the USA300 type S. aureus
clinical isolate LAC (WT). Bacterial strains were routinely grown on tryptic soy
broth (TSB) solidified with 1.5% agar at 37C or in TSB with shaking at
180 rpm, unless otherwise indicated. TSB was supplemented with 10 mg/ml
erythromycin where indicated. Erythromycin-sensitive LAC (AH1263), Dsae,
Dagr, Dagr/sae, FPR3757 Dsae/aur, and Newman Dpsma1-4 were previously
described (Beenken et al., 2010; Benson et al., 2012; Boles et al., 2010; Kaito
et al., 2011; Mrak et al., 2012). Strain Dsae/aur was created by bacteriophage
phi-85-mediated transduction of the aur::erm mutation from FPR3757 Dsae/
aur into the LAC Dsae background as previously described (Mazmanian
et al., 2003). StrainDpsma1-4was created by bacteriophage phi-85-mediated
transduction of the psma1-4::erm mutation from Newman Dpsma1-4 into
LAC. Successful transduction was confirmed by targeted PCR, hemolysis
pattern, and exoprotein pattern (data not shown).
Murine Model of Osteomyelitis
Bacterial inocula were prepared by 1:100 subculture of overnight TSB cultures
followed by growth at 37C and 180 rpm shaking for 3 hr. Bacteria were
collected by centrifugation, washed with PBS, and resuspended to a concen-
tration of 13 106 cfu in 2 ml PBS. Prior to surgery, 7- to 8-week-old C57BL/6J
mice received 0.1 mg/kg buprenorphine via subcutaneous injection. Anes-
thesia was accomplished with isoflurane. The left hindlimb was shaved and
disinfected, and a small incision was made overlying the lateral aspect of
the left femur. The femur was exposedwith blunt dissection, and a 1mmdiam-
eter unicortical bone defect was created at the midfemur by trephination with a
21-gauge PrecisionGlide needle (Becton Dickinson). Bacterial inocula (13 106
cfu in 2 ml) were delivered through the bone defect into the intramedullary
canal. Muscle fasciae and skin were then closed with suture, and mice wereInc.
Figure 5. Alpha-Type Phenol-Soluble Modulins Are Aureolysin-Processed Peptides that Trigger Osteoblast Cell Death In Vitro and
Contribute to Cortical Bone Destruction In Vivo
(A) MC3T3 cells (5,000 cells per well) were incubated with 40 ml concentrated culture supernatant from the indicated strains or an equivalent volume of sterile
RPMI supplemented with 1% casamino acids (control). Osteoblast viability was assessed 23 hr later with the Promega CellTiter 96 AQueous One kit, and
results are expressed as percent of control. n = 10 per group and results are representative of at least three independent experiments. Error bars indicate the
SEM. ***p < 0.001 as calculated by a Student’s t test.
(B and C) Groups of mice were subjected to experimental osteomyelitis via inoculation of WT, Dsae, or Dsae/aur. Femurs were harvested at 14 days post-
inoculation and processed for bacterial recovery (n = 10 per group; B) or subjected to microCT imaging analysis of cortical bone destruction (n = 5 per group; C).
Error bars indicate the SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 as calculated by a Student’s t test. Horizontal bars represent the mean of log cfu/mg of bone.
(D and E) MC3T3 (D) or Saos-2 (E) cell monolayers were incubated with 40 ml concentrated culture supernatant from the indicated strains or an equivalent
volume of sterile RPMI supplemented with 1% casamino acids (control). Osteoblast viability was determined 23 hr later as above. Error bars indicate the SEM.
***p < 0.001 as calculated by a Student’s t test.
(F) Groups of mice (n = 10 per group) were subjected to experimental osteomyelitis via inoculation of WT or Dpsma1-4. Femurs were harvested at 14 days
postinoculation and subjected to microCT imaging analysis of cortical bone destruction. Error bars indicate the SEM. *p < 0.05 relative to WT as calculated by a
Student’s t test.
See also Figure S3.
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72 hr postoperatively, and then as needed thereafter. Infection was allowed
to proceed for 14 days, at which time mice were euthanized and the left femur
was removed and subjected to either microCT or processed for cfu enumera-
tion. For cfu enumeration, femurs were separated from surrounding soft tissue,
frozen in liquid nitrogen, and homogenized in a BioSpec Biopulverizer
(Biospec Products). Homogenized bone was weighed and subsequently re-
suspended in 1 ml PBS prior to sonication in an ice water bath for 30 min.
Sonicated homogenates were vortexed for 60 s and then serially diluted and
plated on TSB solidified with 1.5% agar. Differences in cfu counts from groups
of mice were analyzed with a Student’s t test.
Microcomputed Tomography
Analysis of cortical bone destruction and new bone formation was determined
by microCT imaging with a mCT50 (Scanco Medical) and the manufacturer’s
analytical software. Axial images of each femur were acquired with 5.0 mm
voxels at 70 kV, 200 mA, 2,000 projections per rotation, and an integration
time of 350 ms in a 10.24 mm field of view. Each imaging scan comprised
1,635 slices (8.125 mm) of the length of the femur, centered on the inoculation
site as visualized in the scout-view radiographs. For analysis of cortical bone
destruction, a volume of interest (VOI) including only the original cortical
bone and any destruction was selected by drawing of inclusive contours on
the periosteal surface and excluding contours on the endosteal surface.
Volume of cortical bone destruction was determined by segmentation of the
image with a lower threshold of 0 and an upper threshold of 595 mg HA/
ccm, sigma 1.3, and support 1, to exclude bone in the analysis. For measure-
ment of new bone volume, an inclusive contour was placed around the outer
perimeter of the bone and an excluding contour was drawn along the pre-
existing periosteal surface. Bone was segmented from nonmineralized tissues
in the VOI with a lower threshold of 400 mg HA/ccm, sigma 1.3, and support 2.
The direct voxel counting method was used for all reported calculations in
each analysis. Differences in cortical bone destruction and peripheral new
bone formation were analyzed with a Student’s t test.
Histopathology
After dissection, femurs were placed in neutral-buffered formalin. After 72 hr of
formalin fixation at 4C, samples were rinsed with deionized water and stored
in 70% ethanol at 4C. Femurs were subsequently decalcified in 20% EDTA
(pH 7.4) at 4C for 4 days. Decalcified samples were then dehydrated and
embedded in paraffin. Serial 4 mm paraffin sections were taken with a Leica
2255RM microtome on Leica Superfrost glass slides. Paraffin sections were
cleared with Histo-Clear, then dehydrated and stained with a modified
H&E-phloxine-orange G stain. With this stain, bone tissue stains yellow to
orange in color, osteoclasts stain a vibrant pink, mesenchymal cells stain
blue, and bacterial biofilm stains pink to bright red.
Osteoblast Cytotoxicity Assays
MC3T3-E1 and Saos-2 cells were obtained from the American Type Culture
Collection (ATCC) and propagated according to ATCC recommendations.
Cells were grown at 37C and 5% CO2 with replacement of media every 2 or
3 days. For cytotoxicity assays, cells were seeded into 96-well tissue culture
grade plates at a density of 2,500 or 5,000 cells per well for MC3T3 cells, or
10,000 cells per well for Saos-2 cells. After 24 hr, growth media was removed
and replaced with media containing various amounts of concentrated
S. aureus culture supernatant or an equivalent volume of sterile RPMI. For
some experiments, varying amounts of unconcentrated, 0.22 mm filter-steril-
ized culture supernatant was added to cell monolayers. Monolayers were
incubated for an additional 23 hr prior to replacement of growth media and
assessment of cell viability with the CellTiter 96 AQueous One kit (Promega)
per the manufacturer’s instructions. So that the ability of alpha-type PSMs
to induce osteoblast cytotoxicity could be tested, PSMa1, PSMa2, PSMa3,
and PSMa4 were synthesized at >90% purity by AAPPTec. Purified peptides
were resuspended in dimethyl sulfoxide and added at varying concentrations
to osteoblast monolayers prior to assessment of cell viability as above. To test
the impact of aureolysin activity on PSM cytotoxicity, purified aureolysin
(Biocentrum) was incubated with PSMa2 and PSMa3 for 8 hr at 37C at a ratio
of 1 mg aureolysin per 2 mg PSM. Aureolysin-processed PSMs were then
added to MC3T3 cell monolayers at 100 mg/ml final concentration, and cyto-770 Cell Host & Microbe 13, 759–772, June 12, 2013 ª2013 Elseviertoxicity was assessed as above. As a control, aureolysin was heat inactivated
for 30 min at 65C prior to prior to incubation with PSMs and assessment of
osteoblast cytotoxicity.
Preparation of Concentrated S. aureus Culture Supernatant
To prepare concentrated culture supernatant, a single bacterial colony was
inoculated into 15 ml RPMI supplemented with 1% casamino acids in a
50ml conical tube. Cultures were grown for 15 hr at 37Cand 180 rpm shaking,
after which time they were normalized to an optical density 600 of 3.5 and
subjected to centrifugation for supernatant collection. Triplicate culture super-
natants were filtered through a 0.22 mm filter, combined, and concentrated
with an Amicon Ultra 3 kDa nominal molecular weight limit centrifugal filter
unit (Millipore) per the manufacturer’s instructions. Supernatants were again
filter sterilized and used immediately for cytotoxicity assays, proteomic anal-
ysis, or SDS-PAGE analysis. Supernatants were routinely plated onto tryptic
soy agar supplemented with 5% sheep’s blood for confirmation of sterility
and hemolysis pattern. For SDS-PAGE analysis, 30 ml concentrated superna-
tant was resuspended in 43 loading buffer and boiled for 10 min. Proteins in
the supernatant were resolved using 15% WT/vol SDS-PAGE and stained
with Coomassie blue prior to digital imaging.
Proteomic Analysis of S. aureus Exoproteins
Concentrated culture supernatants were prepared from WT, Dsae, and Dsae/
aur as outlined above. Supernatants were resuspended in LDS sample buffer
(Life Technologies) prior to resolution of the proteins at approximately 1 cm
with a 10% Novex precast gel. Resolved proteins were subjected to in-gel
tryptic digestion to recover peptides. Recovered peptides were analyzed via
MudPIT (Multidimensional Protein Identification Technology) per previously
published protocols (MacCoss et al., 2002; Martinez et al., 2012). In brief, di-
gested peptides were loaded onto a biphasic precolumn consisting of 4 cm of
reversed phase (RP) material followed by 4 cm of strong cation exchange
(RP) material. Once loaded, the column was placed in line with a 20 cm RP
analytical columnpacked intoananosprayemitter tipdirectly coupled toa linear
ion trap mass spectrometer (LTQ). A subset of peptides was eluted from the
SCX material onto the RP analytical via a pulse of volatile salt, separated by
an RP gradient, and then ionized directly into the mass spectrometer where
both the intact masses (mass spectrometry) and fragmentation patterns (tan-
demmassspectrometry) of thepeptideswere collected. Thesepeptide spectral
dataweresearchedagainst aproteindatabasewithSequest (Yates et al., 1995),
and the resulting identifications were collated and filtered with IDPicker (Ma
et al., 2009) and Scaffold (Proteome Software). Relative protein abundances
were evaluated via spectral counting techniques using the QuasiTel program
to calculate false discovery rate-corrected p values (Li et al., 2010).
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